Fri, September 13, 2024
Thu, September 12, 2024
Wed, September 11, 2024
Tue, September 10, 2024
Mon, September 9, 2024

Yigal Nochomovitz Maintained (avbp) at Strong Buy with Increased Target to $36 on, Sep 11th, 2024


//stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-36-on-sep-11th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "ArriVent BioPharma, Inc." (AVBP) at Strong Buy with Increased Target from $30 to $36 on, Sep 11th, 2024.

Yigal has made no other calls on AVBP in the last 4 months.



There are 3 other peers that have a rating on AVBP. Out of the 3 peers that are also analyzing AVBP, 0 agree with Yigal's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Yigal


  • Corinne Johnson of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, September 10th, 2024
  • Jeff Jones of "Oppenheimer" Reiterated at Buy with Increased Target to $39 on, Tuesday, September 10th, 2024
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $36 on, Tuesday, September 10th, 2024

Publication Contributing Sources